The Conversation (0)
RTE News reports that a small Irish drug company has secured multi-million-euro funding to research a new drug to treat a range of gastrointestinal disorders and other conditions.
RTE News reports that a small Irish drug company has secured multi-million-euro funding to research a new drug to treat a range of gastrointestinal disorders and other conditions.
As quoted in the market news:
Trino Therapeutics secured the €9m in funding from a new investor, Fountain Healthcare Partners, and its founding investor, Britain-based global charitable foundation the Wellcome Trust. The drug is based on a molecule derived from a fern found in Taiwan.